| 1 |
34393203 | Kappa opioid receptor blockade in the nucleus accumbens shell prevents sex-dependent alcohol deprivation effect induced by inflammatory pain. | 2022 Jan 1 |
1 |
| 2 |
33489124 | Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease. | 2021 |
2 |
| 3 |
33599108 | Synthesis and Assessment of Fused β-Carboline Derivatives as Kappa Opioid Receptor Agonists. | 2021 Jun 17 |
1 |
| 4 |
33766518 | Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain. | 2021 Jul 1 |
2 |
| 5 |
34597607 | Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence. | 2021 Nov 15 |
1 |
| 6 |
31870854 | The kappa opioid receptor modulates GABA neuron excitability and synaptic transmission in midbrainprojections from the insular cortex. | 2020 Mar 15 |
2 |
| 7 |
32511908 | Targeting Nitric Oxide Production in Microglia with Novel Imidazodiazepines for Nonsedative Pain Treatment. | 2020 Jul 1 |
1 |
| 8 |
30414973 | Kappa opioid receptors mediate yohimbine-induced increases in impulsivity in the 5-choice serial reaction time task. | 2019 Feb 1 |
2 |
| 9 |
30908671 | Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice. | 2019 Jun |
2 |
| 10 |
31461637 | Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK/Mfn2 activation. | 2019 Dec |
2 |
| 11 |
29371114 | A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. | 2018 Jun |
1 |
| 12 |
28088389 | Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor. | 2017 Apr |
1 |
| 13 |
28347824 | Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI. | 2017 Jun 1 |
2 |
| 14 |
25593096 | Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. | 2015 Jul 15 |
1 |
| 15 |
25971593 | Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs. | 2015 Dec |
2 |
| 16 |
26501171 | Kappa-opioid antagonism impairs forebrain-dependent associative learning: A trace eyeblink conditioning study. | 2015 Dec |
1 |
| 17 |
24690494 | Antagonists of the kappa opioid receptor. | 2014 May 1 |
1 |
| 18 |
24796820 | Brief prenatal ethanol exposure alters behavioral sensitivity to the kappa opioid receptor agonist (U62,066E) and antagonist (Nor-BNI) and reduces kappa opioid receptor expression. | 2014 Jun |
1 |
| 19 |
24930486 | A cell-based, high-throughput homogeneous time-resolved fluorescence assay for the screening of potential κ-opioid receptor agonists. | 2014 Jul |
1 |
| 20 |
23689673 | Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats. | 2013 Oct |
4 |
| 21 |
21484425 | Local kappa opioid receptor activation decreases temporomandibular joint inflammation. | 2012 Feb |
1 |
| 22 |
22343623 | Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells. | 2012 Mar 13 |
1 |
| 23 |
20813108 | SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects. | 2010 Nov 25 |
1 |
| 24 |
18048026 | Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. | 2008 Feb 12 |
1 |
| 25 |
18178175 | The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. | 2008 Feb 8 |
1 |
| 26 |
18183621 | YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment. | 2008 May 15 |
2 |
| 27 |
18571771 | Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2. | 2008 Sep |
1 |
| 28 |
19110556 | Role of opioid system in modulation of pain sensitivity under conditons of low and high environmental temperature. | 2008 Jun |
1 |
| 29 |
17538007 | Human neural precursor cells express functional kappa-opioid receptors. | 2007 Sep |
3 |
| 30 |
17917294 | Catalytic aerobic oxidation of nor-binaltorphimine (nor-BNI) analogs without 4,5-epoxy bridge affords a more selective ligand for kappa opioid receptor than the representative kappa antagonist nor-BNI. | 2007 Oct |
3 |
| 31 |
16434091 | Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. | 2006 Jan |
2 |
| 32 |
15456805 | Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception. | 2005 Mar |
2 |
| 33 |
15743210 | Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist. | 2005 Mar 10 |
2 |
| 34 |
15953492 | Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats. | 2005 Jun 15 |
1 |
| 35 |
14757131 | Kappa-opioid receptors are differentially labeled by arylacetamides and benzomorphans. | 2004 Feb 6 |
1 |
| 36 |
14757849 | Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. | 2004 May |
1 |
| 37 |
12473373 | U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. | 2003 Jan 1 |
2 |
| 38 |
12649366 | Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. | 2003 Apr |
1 |
| 39 |
12706459 | Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion. | 2003 Apr 25 |
1 |
| 40 |
12815037 | Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. | 2003 Sep 5 |
1 |
| 41 |
12915238 | Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. | 2003 Aug 22 |
7 |
| 42 |
14602811 | Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. | 2003 Nov 5 |
2 |
| 43 |
11931835 | Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. | 2002 Mar 15 |
2 |
| 44 |
21174814 | [Inhibitory effects of kappa-opioid receptor stimulation on cultured myocardial cells]. | 2002 Nov |
1 |
| 45 |
11245971 | U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages. | 2001 Apr 1 |
2 |
| 46 |
11301048 | Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. | 2001 May 1 |
4 |
| 47 |
11562065 | Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. | 2001 Sep |
1 |
| 48 |
11727785 | Morphine upregulates kappa-opioid receptors of human lymphocytes. | 2001 |
1 |
| 49 |
10665828 | U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression. | 2000 |
1 |
| 50 |
10746640 | Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus. | 2000 Apr |
1 |